We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia (CELMA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04429763
Recruitment Status : Unknown
Verified June 2020 by Trustem.
Recruitment status was:  Not yet recruiting
First Posted : June 12, 2020
Last Update Posted : June 12, 2020
Sponsor:
Collaborators:
Fundación Universitaria de Ciencias de la Salud
Hospital de San Jose
Hospital Infantil Universitario de San Jose
Information provided by (Responsible Party):
Trustem

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : September 2020
Estimated Study Completion Date : November 2020